Cargando…
Adapting Inhaled Medication Practice in COPD and Asthma to Avoid Funding the Tobacco Industry [Corrigendum]
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8646108/ https://www.ncbi.nlm.nih.gov/pubmed/34880608 http://dx.doi.org/10.2147/COPD.S349143 |
Ejemplares similares
-
Adapting Inhaled Medication Practice in COPD and Asthma to Avoid Funding the Tobacco Industry
por: Capstick, Toby G D, et al.
Publicado: (2021) -
The use of multiple respiratory inhalers requiring different inhalation techniques has an adverse effect on COPD outcomes [Corrigendum]
Publicado: (2019) -
Inhaled Corticosteroid Treatment Regimens and Health Outcomes in a UK COPD Population Study [Corrigendum]
Publicado: (2020) -
A randomised open-label cross-over study of inhaler errors, preference and time to achieve correct inhaler use in patients with COPD or asthma: comparison of ELLIPTA with other inhaler devices
por: van der Palen, Job, et al.
Publicado: (2017) -
Impaired Training-Induced Adaptation of Blood Pressure in COPD Patients: Implication of the Muscle Capillary Bed [Corrigendum]
Publicado: (2020)